Metaanalysis vs large clinical trials: which should guide our management?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19027095.
- Also identified by DOI 10.1016/j.ajog.2008.09.873 and PMC identifier 5813486.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Large, randomized clinical trials have long been considered the gold standard to guide clinical care. Metaanalysis is a type of analysis in which results of a number of randomized clinical trials are combined and a summary measure of effect for a given treatment is ascertained. The clinician in practice often is faced with a dilemma regarding the type of evidence that should be used to guide clinical practice; for many clinical problems, there are both randomized controlled trials and metaanalyses available. The cases of calcium and aspirin therapy for the prevention of preeclampsia afford an opportunity to explore the benefits and limitations of each type of study to guide clinical practice. We conclude that, when available, large randomized clinical trials should be used to guide clinical practice.
Medical subject headings
- Meta-Analysis as Topic
- Pregnancy Complications
- Randomized Controlled Trials as Topic